206 related articles for article (PubMed ID: 17040199)
1. Pancreatic cancer: a review of recent advances.
Eckel F; Schneider G; Schmid RM
Expert Opin Investig Drugs; 2006 Nov; 15(11):1395-410. PubMed ID: 17040199
[TBL] [Abstract][Full Text] [Related]
2. Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
Li J; Saif MW
JOP; 2009 Jul; 10(4):361-5. PubMed ID: 19581735
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy for pancreatic cancer].
Kim YT
Korean J Gastroenterol; 2008 Feb; 51(2):111-8. PubMed ID: 18349573
[TBL] [Abstract][Full Text] [Related]
4. [Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer].
Ryu JK
Korean J Gastroenterol; 2015 Sep; 66(3):150-3. PubMed ID: 26387697
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions.
Xiong HQ; Carr K; Abbruzzese JL
Drugs; 2006; 66(8):1059-72. PubMed ID: 16789792
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Oláh A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Büchler MW;
JAMA; 2010 Sep; 304(10):1073-81. PubMed ID: 20823433
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs in pancreatic cancer.
Ducreux M; Boige V; Malka D
Expert Opin Emerg Drugs; 2004 May; 9(1):73-89. PubMed ID: 15155137
[TBL] [Abstract][Full Text] [Related]
8. Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
Saif MW
JOP; 2008 Mar; 9(2):91-8. PubMed ID: 18326919
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.
Saif MW
JOP; 2007 Jul; 8(4):365-73. PubMed ID: 17625289
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer.
Li D; Xie K; Wolff R; Abbruzzese JL
Lancet; 2004 Mar; 363(9414):1049-57. PubMed ID: 15051286
[TBL] [Abstract][Full Text] [Related]
11. What's new in pancreatic cancer treatment?
Fung MC; Sakata T
J Hepatobiliary Pancreat Surg; 2002; 9(1):61-75. PubMed ID: 12021899
[TBL] [Abstract][Full Text] [Related]
12. Current Standard and Future Perspectives in First- and Second-Line Treatment of Metastatic Pancreatic Adenocarcinoma.
Ellenrieder V; König A; Seufferlein T
Digestion; 2016; 94(1):44-9. PubMed ID: 27438590
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.
Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D
Cochrane Database Syst Rev; 2006 Jul; (3):CD002093. PubMed ID: 16855985
[TBL] [Abstract][Full Text] [Related]
14. Conventional chemotherapy of advanced pancreatic cancer.
Giuliani F; Di Maio M; Colucci G; Perrone F
Curr Drug Targets; 2012 Jun; 13(6):795-801. PubMed ID: 22458526
[TBL] [Abstract][Full Text] [Related]
15. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for advanced pancreatic cancer.
Chua YJ; Cunningham D
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):327-48. PubMed ID: 16549331
[TBL] [Abstract][Full Text] [Related]
17. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
19. Metastatic pancreatic cancer 2008: is the glass less empty?
Nieto J; Grossbard ML; Kozuch P
Oncologist; 2008 May; 13(5):562-76. PubMed ID: 18515741
[TBL] [Abstract][Full Text] [Related]
20. The role of gemcitabine alone and in combination in the treatment of pancreatic cancer.
Oettle H; Arnold D; Hempel C; Riess H
Anticancer Drugs; 2000 Nov; 11(10):771-86. PubMed ID: 11142685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]